Patents

US 9925250 B2: Method of treating proteinuria in pregnancy

Granted
2018-03-27
Filed
2016-06-17 application 15185511
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and a method for preparing the therapeutic agent are disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or by other methods. Further, a method of using the presence of chymotrypsin in the maternal GI tract as a biomarker, to determine the likelihood of developing preeclampsia, a pregnancy induced hypertension, and eclampsia/toxemia is disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg180327.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CUREMARK, LLC 55 patentsUS company or organizationRye, NYCUREMARK, LLC State business registration EXACT high confidence: identical full name and state
CUREMARK LLC Form D issuer EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Joan M. FallonBronxville, NY61PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/54PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P9/12PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y301/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-10-05Correction
Corrective assignment to correct the assignee - curemark llc previously recorded on reel 039067 frame 0268. assignor(s) hereby confirms the the correct assignee is curemark, llc.
FALLON, JOAN M. signed 2013-10-11CUREMARK, LLC RYE, NY40234/595ECORSEXC, file of 2026-09-25
2016-07-01Assignment
Assignment of assignor's interest
FALLON, JOAN M. signed 2013-10-11CUREMARK LLC RYE, NY39067/268ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.